Celltrion
068270.KS
#748
Rank
S$35.84 B
Marketcap
$173.04
Share price
0.72%
Change (1 day)
6.50%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2024 (TTM): S$2.66 Billion

According to Celltrion 's latest financial reports the company's current revenue (TTM ) is S$2.61 Billion. In 2023 the company made a revenue of S$2.17 Billion a decrease over the revenue in the year 2022 that were of S$2.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$2.66 B22.46%
2023 S$2.17 B-7.3%
2022 S$2.35 B5.6%
2021 S$2.22 B5.72%
2020 S$2.10 B61.04%
2019 S$1.30 B7.18%
2018 S$1.21 B7.2%
2017 S$1.13 B35.16%
2016 S$0.84 B13.66%
2015 S$0.74 B24.75%
2014 S$0.59 B126.42%
2013 S$0.26 B-33.23%
2012 S$0.39 B
2010 S$0.20 B23.5%
2009 S$0.16 B58.9%
2008 S$0.10 B